{"entity":{"type":"insider","cik":"0001680739","url":"/insider/0001680739","json_url":"/insider/0001680739.json","name":"Baynes Roy D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":10,"first":"2020-08-11","last":"2026-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Baynes Roy D.","source":"filing","n_filings":10,"first_seen":"2020-08-11","last_seen":"2026-06-16"}],"transactions":[{"id":5778737,"accession":"0001680739-26-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680739-26-000014","line_url":"/filing/0001680739-26-000014#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":41500.0,"shares_owned_after_display":"41,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-16","scope":"insider"},{"id":6139927,"accession":"0001680739-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680739-26-000008","line_url":"/filing/0001680739-26-000008#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":46.65,"price_display":"46.65","price_state":"stated","total_value":209925.0,"total_display":"209,925.00","total_whole":"209,925","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-06","scope":"insider"},{"id":5875569,"accession":"0001680739-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680739-26-000007","line_url":"/filing/0001680739-26-000007#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9750.0,"shares_display":"9,750","price_per_share":44.22,"price_display":"44.22","price_state":"stated","total_value":431145.0,"total_display":"431,145.00","total_whole":"431,145","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-04","scope":"insider"},{"id":6114175,"accession":"0001680739-26-000005","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001680739-26-000005","line_url":"/filing/0001680739-26-000005","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32750.0,"shares_display":"32,750","price_per_share":41.286412213740455,"price_display":"41.29","price_state":"stated","total_value":1352130.0,"total_display":"1,352,130.00","total_whole":"1,352,130","shares_owned_after":44250.0,"shares_owned_after_display":"44,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-14","filed_date":"2026-04-16","scope":"insider","n_lines":2},{"id":6174783,"accession":"0001680739-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001680739-26-000003","line_url":"/filing/0001680739-26-000003#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":330000.0,"total_display":"330,000.00","total_whole":"330,000","shares_owned_after":37500.0,"shares_owned_after_display":"37,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-07","scope":"insider"},{"id":4962268,"accession":"0001680739-25-000007","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001680739-25-000007","line_url":"/filing/0001680739-25-000007","is_derivative":false,"issuer_cik":"0001604821","issuer_name":"Natera, Inc.","issuer_ticker":"NTRA","issuer_name_source":null,"issuer_url":"/issuer/0001604821","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7668.0,"shares_display":"7,668","price_per_share":223.08297089201878,"price_display":"223.08","price_state":"stated","total_value":1710600.2208,"total_display":"1,710,600.22","total_whole":"1,710,600","shares_owned_after":20243.0,"shares_owned_after_display":"20,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-21","scope":"insider","n_lines":5},{"id":4962224,"accession":"0001680739-25-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001680739-25-000007","line_url":"/filing/0001680739-25-000007","is_derivative":false,"issuer_cik":"0001604821","issuer_name":"Natera, Inc.","issuer_ticker":"NTRA","issuer_name_source":null,"issuer_url":"/issuer/0001604821","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5112.0,"shares_display":"5,112","price_per_share":215.00164166666667,"price_display":"215.00","price_state":"stated","total_value":1099088.3922,"total_display":"1,099,088.39","total_whole":"1,099,088","shares_owned_after":18359.0,"shares_owned_after_display":"18,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-21","scope":"insider","n_lines":3},{"id":5038077,"accession":"0001415889-25-003529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-003529","line_url":"/filing/0001415889-25-003529#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":220000.0,"total_display":"220,000.00","total_whole":"220,000","shares_owned_after":31000.0,"shares_owned_after_display":"31,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-06","filed_date":"2025-02-10","scope":"insider"},{"id":5122176,"accession":"0001415889-25-002003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002003","line_url":"/filing/0001415889-25-002003#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":320000.0,"total_display":"320,000.00","total_whole":"320,000","shares_owned_after":31000.0,"shares_owned_after_display":"31,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-23","filed_date":"2025-01-23","scope":"insider"},{"id":2257482,"accession":"0001415889-24-027020","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-027020","line_url":"/filing/0001415889-24-027020","is_derivative":false,"issuer_cik":"0001604821","issuer_name":"Natera, Inc.","issuer_ticker":"NTRA","issuer_name_source":null,"issuer_url":"/issuer/0001604821","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37230.0,"shares_display":"37,230","price_per_share":146.10702678485092,"price_display":"146.11","price_state":"stated","total_value":5439564.6072,"total_display":"5,439,564.61","total_whole":"5,439,565","shares_owned_after":31133.0,"shares_owned_after_display":"31,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-15","scope":"insider","n_lines":6},{"id":2973651,"accession":"0001179110-20-008903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008903","line_url":"/filing/0001179110-20-008903#line-2","is_derivative":false,"issuer_cik":"0001604821","issuer_name":"Natera, Inc.","issuer_ticker":"NTRA","issuer_name_source":null,"issuer_url":"/issuer/0001604821","owner_cik":"0001680739","owner_name":"Baynes Roy D.","owner_display_name":"Baynes Roy D.","owner_url":"/insider/0001680739","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":53.4715,"price_display":"53.47","price_state":"stated","total_value":69512.95,"total_display":"69,512.95","total_whole":"69,513","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-07","filed_date":"2020-08-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Travere Therapeutics, Inc.","url":"/issuer/0001438533","role":"Director","n_filings":7,"first_seen":"2025-01-23","last_seen":"2026-06-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001604821","name":"Natera, Inc.","url":"/issuer/0001604821","role":"Director","n_filings":3,"first_seen":"2020-08-11","last_seen":"2025-11-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001680739","retrieved_at":"2026-08-23T23:00:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}